Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael E Phelps

Showing results (41-50 of 142) with videos related to

Pageof 15
Sort By:
Chest|October 21, 2005
Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusionBenjamin S Halpern, Christiaan Schiepers, Wolfgang A Weber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 9, 2002
Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patientsDuska Vranjesevic, Jean Emmanuel Filmont, Joubin Meta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2011
Discriminant analysis of ¹⁸F-fluorothymidine kinetic parameters to predict survival in patients with recurrent high-grade gliomaMirwais Wardak, Christiaan Schiepers, Magnus Dahlbom, et al.
Archives of General Psychiatry|April 6, 2006
Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer diseaseLinda Ercoli, Prabha Siddarth, Sung-Cheng Huang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2006
Impact of animal handling on the results of 18F-FDG PET studies in miceBarbara J Fueger, Johannes Czernin, Isabel Hildebrandt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 17, 2008
Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumorsMatthias R Benz, Vladimir Evilevitch, Martin S Allen-Auerbach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitorsHelen Su, Claudia Bodenstein, Rebecca A Dumont, et al.
Nuclear Medicine and Biology|May 10, 2005
Imaging beta-amyloid fibrils in Alzheimer's disease: a critical analysis through simulation of amyloid fibril polymerizationKooresh Shoghi-Jadid, Jorge R Barrio, Vladimir Kepe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2013
(18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatmentKarlo J Lizarraga, Martin Allen-Auerbach, Johannes Czernin, et al.
Molecular Imaging and Biology|October 11, 2003
Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairmentDaniel H S Silverman, Jeffrey L Cummings, Gary W Small, et al.
Pageof 15

Showing results (41-50 of 142) with videos related to

Sort By:
Pageof 15
Chest|October 21, 2005
Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusionBenjamin S Halpern, Christiaan Schiepers, Wolfgang A Weber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 9, 2002
Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patientsDuska Vranjesevic, Jean Emmanuel Filmont, Joubin Meta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2011
Discriminant analysis of ¹⁸F-fluorothymidine kinetic parameters to predict survival in patients with recurrent high-grade gliomaMirwais Wardak, Christiaan Schiepers, Magnus Dahlbom, et al.
Archives of General Psychiatry|April 6, 2006
Perceived loss of memory ability and cerebral metabolic decline in persons with the apolipoprotein E-IV genetic risk for Alzheimer diseaseLinda Ercoli, Prabha Siddarth, Sung-Cheng Huang, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2006
Impact of animal handling on the results of 18F-FDG PET studies in miceBarbara J Fueger, Johannes Czernin, Isabel Hildebrandt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 17, 2008
Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumorsMatthias R Benz, Vladimir Evilevitch, Martin S Allen-Auerbach, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitorsHelen Su, Claudia Bodenstein, Rebecca A Dumont, et al.
Nuclear Medicine and Biology|May 10, 2005
Imaging beta-amyloid fibrils in Alzheimer's disease: a critical analysis through simulation of amyloid fibril polymerizationKooresh Shoghi-Jadid, Jorge R Barrio, Vladimir Kepe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2013
(18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatmentKarlo J Lizarraga, Martin Allen-Auerbach, Johannes Czernin, et al.
Molecular Imaging and Biology|October 11, 2003
Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairmentDaniel H S Silverman, Jeffrey L Cummings, Gary W Small, et al.
Pageof 15